BlackRock, Inc. 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-07-08 4:32 pm Purchase | 2024-06-30 | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 3,947,588 13.800% | 2,138,211![]() (+118.17%) | Filing |
2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,809,377 6.400% | 110,952![]() (+6.53%) | Filing |
2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,698,425 6.600% | 92,929![]() (+5.79%) | Filing |
2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,605,496 6.400% | 198,148![]() (+14.08%) | Filing |
2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,407,348 7.100% | 1,407,348![]() (New Position) | Filing |